Xos 10-Q: Going Concern Reaffirmed, $12.1M Cash, Q3 Loss $7.6M
XOS sits 37% above its 52-week low of $1.6.
Summary
Xos's Q3 10-Q reaffirms substantial doubt about going concern with explicit bankruptcy language, shows $12.1M cash after a $6.8M nine-month operating burn, and discloses a new material weakness plus CEO and CFO 10b5-1 selling plans.
Key Events · Earnings and Guidance · XOS
-
Going Concern Doubt Reaffirmed
Management states it is not probable its plans alleviate substantial doubt about continuing as a going concern for one year, and that absent new capital, receivable collections or debt relief the company could be required to seek protection under Chapters 7 or 11 of the U.S. Bankruptcy Code.
-
Cash Down to $12.1M
Cash and equivalents fell to $12.1M at September 30, 2026 from $14.0M at December 31, 2025, after $6.8M of net cash used in operating activities over nine months and a $19.4M net loss.
-
Q3 Loss $7.6M on $5.5M Revenue
Third-quarter revenue was $5.5M against a $7.6M net loss; gross profit was $850K. Nine-month revenue of $21.5M was down 47% from $40.8M a year earlier.
-
ATM Is the Remaining Funding Lever
637,409 shares were sold under the ATM in Q3 at a $4.67 average for $2.8M net, and 1,016,109 shares over nine months at $5.43 for $5.1M net; only $5.8M remained available under the prospectus supplement at quarter-end.
Analysis · XOS · Manufacturing
The Q3 8-K gave the headline numbers; this 10-Q supplies the balance sheet behind them, and it is grim. Xos ended September with $12.1M of cash against $14.0M at year-end, after burning $6.8M in operations over nine months and posting a $19.4M net loss. Management states plainly that it is not probable its plans alleviate substantial doubt about continuing as a going concern, and that absent new capital, receivable collections or debt relief the company could seek Chapter 7 or 11 protection. The only funding lever left is the ATM, which had $5.8M available at quarter-end and was already used for 637,409 shares at a $4.67 average in Q3 — well above today's $2.19, meaning further sales raise far less per share. Layered on top: a newly disclosed material weakness in vendor accrual accounting and disclosure controls deemed ineffective, plus fresh 10b5-1 selling plans from the CEO (400,360 shares) and CFO (55,879 shares).
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XOS was trading at $2.19 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $32.6M. The 52-week trading range was $1.60 to $8.27. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.